NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.
| Website: | www.neogenomics.com |
| Email: | bill.bonello@neogenomics.com |
| Main Phone: | +1 239 768-0600 |
| Address: | 12701 Commonwealth Drive |
| Address 2: | Suite 9 |
| State: | FL |
| City / Town: | Fort Myers |
| Country: | USA |
| Postal Code: | 33913 |
| Exchange: | NSC |
| CEO: | Douglas M. VanOort |
| Employees: | 1030 |
| NAICS: | Research and Development in Biotechnology (except Nanobiotechnology)(541714) |
| Last Price 12.81 | Change $ -0.44 | Change % -3.32 | Tick N/A |
| Bid 12.81 | Bid Size 500.00 | Ask 12.87 | Ask Size 400.00 |
| Open 13.18 | High 13.24 | Low 12.81 | Prev Close 13.25 |
| Last Trade | Volume 15,090 | 52 Wk Hi 19.04 | 52 Wk Low 7.08 |
| Market Cap 1.2 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 94,016,722.00 | EPS (TTM) 0.08 | PE Ratio 165.60 | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 32 | 42 |
| Number of Buys | 20 | 26 |
| Number of Sells | 12 | 16 |
| Net Activity | -231499 | -228889 |
| Last 10 Buys | Shares |
|---|---|
| Alison L. Hannah | 1,000 |
| Kevin Johnson | 1,000 |
| Alison L. Hannah | 1,000 |
| Kevin Johnson | 1,000 |
| Lynn A. Tetrault | 1,000 |
| Lynn A. Tetrault | 1,000 |
| Robert J. Shovlin | 1,000 |
| Bruce K. Crowther | 1,000 |
| Maher Albitar | 1,000 |
| Stephen J. Clearman | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Steven C. Jones | 1,000 |
| Steven C. Jones | 1,000 |
| Steven C. Jones | 1,000 |
| Steven C. Jones | 1,000 |
| Jennifer Balliet | 1,000 |
| Jennifer Balliet | 1,000 |
| Jennifer Balliet | 1,000 |
| Jennifer Balliet | 1,000 |
| Steven A. Ross | 1,000 |
| Jennifer Balliet | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 13 | 11 | 11 | 14 |
| Low Target Price Estimate | 10 | 10 | 10 | 10 |
| Mean Target Price Estimate | 11.2 | 10.8 | 10.8 | 11.8 |
| Standard Deviation | 1.1 | 0.45 | 0.45 | 1.64 |
| Date of Most Recent Estimate | 06/04/18 | 05/15/18 | 05/02/18 | 06/07/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate changes. | 40 | 2018-06-12 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-06-06 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| 8-K | Report of unscheduled material events or corporate changes. | 5 | 2018-06-01 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-31 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 5 | 5 | 6 | 6 |
| Moderate Buy | 0 | 0 | 0 | 1 |
| Hold | 1 | 1 | 1 | 1 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.33 | 1.33 | 1.29 | 1.38 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
